ROCHE HOLDING (UK) LIMITED
Get an alert when ROCHE HOLDING (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£57M
+85.6% vs 2024
Net assets
£162M
+23.7% highest in 3 filed years
Employees
0
Average over period
Profit before tax
£31M
+0.5% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The financial statements have been prepared on the going concern basis, notwithstanding net current liabilities of £33,534,193, as at 31 December 2025. The Company is dependent for its working capital on funds provided to it by Roche Products Limited, which has indicated its intention to continue to make available such funds.
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | — | £30,805,000 | £29,827,000 | -3.2% | |
| Profit before tax | £36,317,000 | £30,833,000 | £30,992,000 | +0.5% | |
| Net profit | £36,317,000 | £30,833,000 | £30,992,000 | +0.5% | |
| Cash | — | £30,833,000 | £57,221,000 | +85.6% | |
| Total assets less current liabilities | — | £130,833,000 | £161,825,000 | +23.7% | |
| Net assets | £100,000,000 | £130,833,000 | £161,825,000 | +23.7% | |
| Equity | £100,000,000 | £130,833,000 | £161,825,000 | +23.7% | |
| Average employees | — | 0 | 0 | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | — | 23.5% | 18.4% | |
| Current ratio | — | 0.32x | 0.63x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The financial statements have been prepared on the going concern basis, notwithstanding net current liabilities of £33,534,193, as at 31 December 2025. The Company is dependent for its working capital on funds provided to it by Roche Products Limited, which has indicated its intention to continue to make available such funds.”
Group structure
- ROCHE HOLDING (UK) LIMITED · parent
- Roche Products Limited 100%
- Roche Diagnostics Limited 100%
- Roche Diabetes Care Limited 100%
- InterMune Holding Ltd 100%
- Roche Products (Ireland) Limited 100%
- LumiraDX UK Limited 100%
- LKM Innovations Limited 100%
- InterMune International AG 100%
- AVL Medical Instruments UK Limited 100%
- Nicholas Laboratories Limited 100%
- Roche Products Pension Trust Limited 100%
- Roche Healthcare Trustee Limited 100%
- Ventana Medical Systems Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 24 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DAVIS, Scott | Secretary | 2019-03-13 | — | — |
| DAVIS, Scott | Director | 2021-03-04 | Nov 1970 | British |
| LOEWENSTEIN, Danielle Lisa | Director | 2025-01-27 | Feb 1984 | Israeli |
| ROWBOTHAM, Kathryn | Director | 2025-08-11 | Aug 1976 | American |
| TRYBUS, Peter | Director | 2023-08-22 | Jun 1979 | Swiss,Austrian |
| WARD, Padraic | Director | 2017-08-01 | Apr 1965 | Irish |
Show 24 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ABIMBOLA, Olufunke | Secretary | 2015-06-22 | 2018-07-06 |
| DANIEL, Richard David | Secretary | 1997-05-13 | 2015-06-22 |
| ROBERTSON, Mandy Elizabeth | Secretary | 2018-07-09 | 2019-03-12 |
| ACKERMANN, Vic | Director | 1997-10-13 | 2000-06-14 |
| BRAEBECK LETMATHE, Andres | Director | 2004-01-09 | 2012-08-31 |
| BURNS, William Murray | Director | 1999-02-22 | 2001-04-05 |
| COOK, Jennifer Elizabeth | Director | 2013-09-01 | 2017-08-01 |
| CUMA, Benan | Director | 2020-11-01 | 2024-07-17 |
| DALLAS, Jayson Donald Alexander | Director | 2013-01-01 | 2015-07-24 |
| ERWIN, Richard William | Director | 2015-09-01 | 2025-07-30 |
| GERBER, Fritz | Director | 1997-05-13 | 1999-02-22 |
| HUG, Peter | Director | 2007-06-01 | 2013-09-01 |
| JACKSON, David James | Director | 1997-10-13 | 2001-09-30 |
| KELLY, Timothy Edwin | Director | 2017-03-01 | 2018-12-31 |
| KRAEHENMANN, Beat Christoph | Director | 2014-03-05 | 2022-07-11 |
| LENNERTZ, James Karin Jnr | Director | 2002-03-01 | 2004-01-09 |
| MEIR, Henri Bernard, Dr | Director | 1997-05-13 | 1999-02-22 |
| MELVILLE, John Mcmillan | Director | 2000-06-14 | 2012-12-31 |
| SCHILKE, Tobin Charles | Director | 2014-08-04 | 2016-06-10 |
| SCHREINER, Claude Georges Charles | Director | 2001-04-05 | 2007-05-31 |
| SCHUMACHER, Christiane | Director | 2016-06-10 | 2017-03-01 |
| VITUG, Kezia Jayn | Director | 2019-03-01 | 2020-10-31 |
| WASEM, Agnes | Director | 2022-07-11 | 2023-08-22 |
| WILLIAMS, Mark Lloyd | Director | 2012-08-31 | 2014-05-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Roche Holding Ag | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-06-01 | Active |
Filing timeline
Last 20 of 134 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-16 | AA | accounts | Accounts with accounts type full | |
| 2026-03-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-19 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-09 | AA | accounts | Accounts with accounts type full | |
| 2025-03-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-04 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-19 | AA | accounts | Accounts with accounts type full | |
| 2024-07-22 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-15 | AA | accounts | Accounts with accounts type full | |
| 2023-08-30 | AP01 | officers | Appoint person director company with name date | |
| 2023-08-30 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-08 | TM01 | officers | Termination director company with name termination date | |
| 2022-07-11 | AP01 | officers | Appoint person director company with name date | |
| 2022-06-28 | AA | accounts | Accounts with accounts type full | |
| 2022-05-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-11-30 | CH01 | officers | Change person director company with change date | |
| 2021-10-15 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.